Scopus BioPharma Inc. (SCPS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 11.71 Million | 27.63 Million | 10.15 Million | 2.68 Million | 685.96 Thousand |
| Selling, General and Administrative Expenses | 9.03 Million | 12.61 Million | 2.73 Million | 2.22 Million | 408.42 Thousand |
| Research and Development Expenses | 2.68 Million | 15.02 Million | 7.42 Million | 463.11 Thousand | 277.53 Thousand |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 11.71 Million | 27.63 Million | 10.15 Million | 2.68 Million | 685.96 Thousand |
| Operating Income | -11.71 Million | -27.63 Million | -10.15 Million | -2.68 Million | -685.96 Thousand |
| Interest Expense | - | 774.67 Thousand | 706.44 Thousand | - | - |
| Income Tax Expense | -105.05 Thousand | 774.67 Thousand | 706.44 Thousand | 1.00 | -847.1 Thousand |
| Earnings before Tax | -11.71 Million | -26.95 Million | -10.86 Million | -2.68 Million | -685.96 Thousand |
| Net Income | -11.6 Million | -27.72 Million | -11.56 Million | -2.68 Million | -685.96 Thousand |
| Earnings Per Share Basic | -0.55 | -1.61 | -0.87 | -0.18 | -0.05 |
| Earnings Per Share Diluted | -0.55 | -1.61 | -0.87 | -0.18 | -0.05 |
| Weighted Average Shares Outstanding | 21.09 Million | 17.25 Million | 13.36 Million | 14.97 Million | 14.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.09 Million | 17.25 Million | 13.36 Million | 14.97 Million | 14.97 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -11.71 Million | -27.63 Million | -10.15 Million | -2.68 Million | -685.96 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2.92 Million | 2.67 Million | 1.83 Million | 11.71 Million | 1.89 Million | 3.31 Million |
| Selling, General and Administrative Expenses | 935.86 Thousand | 1.07 Million | 1.08 Million | - | 981.34 Thousand | 2.67 Million |
| Research and Development Expenses | 1.99 Million | 1.6 Million | 745.9 Thousand | - | 917.26 Thousand | 649.46 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.92 Million | 2.67 Million | 1.83 Million | 11.71 Million | 1.89 Million | 3.31 Million |
| Operating Income | -2.61 Billion | -2.67 Million | -1.83 Million | -11.71 Million | -1.89 Million | -3.31 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 2.61 Billion | -229.83 Thousand | -105.05 Thousand | -105.05 Thousand | -26.77 Thousand | - |
| Earnings before Tax | -2.92 Million | -2.67 Million | -1.83 Million | -11.71 Million | -1.89 Million | -3.31 Million |
| Net Income | -2.61 Million | -2.44 Million | -1.73 Million | -11.6 Million | -1.89 Million | -3.31 Million |
| Earnings Per Share Basic | -0.07 | -0.08 | -0.08 | - | -0.09 | -0.16 |
| Earnings Per Share Diluted | -0.07 | -0.08 | -0.08 | - | -0.09 | -0.16 |
| Weighted Average Shares Outstanding | 39.74 Million | 30.36 Million | 21.09 Million | 21.09 Million | 21.09 Million | 21.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.74 Million | 30.36 Million | 21.09 Million | 21.09 Million | 21.09 Million | 21.09 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.92 Million | -2.67 Million | -1.83 Million | - | -1.89 Million | -3.31 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FLEXITUFF
8529
BEEP
VTSI
600392
2139